血小板源性hsa_circ_0001535与急性冠脉综合征患者双联抗血小板治疗后抗血小板反应性的相关性
CSTR:
作者:
作者单位:

(1.解放军医学院,北京 100853;2.中国人民解放军总医院第二医学中心老年医学研究所,国家老年疾病临床医学研究中心,北京 100853)

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(82170352,82472193);国家老年疾病临床医学研究中心开放课题(NCRCG-PLAGH-2024004)


Correlation between platelet-derived hsa_circ_0001535 and antiplatelet reactivity in patients with acute coronary syndrome after dual anti-platelet therapy
Author:
Affiliation:

(1.Chinese PLA Medical School, Beijing 100853, China;2. Institute of Geriatrics of Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China)

Fund Project:

This work was supported byGeneral Program of National Natural Science Foundation of China(82170352;82472193)and Open Project of National Clinical Research Center forGeriatric Diseases(NCRCG-PLAGH-2024OO4).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨血小板源性hsa_circ_0001535的相对表达水平,并分析其与急性冠脉综合征(ACS)患者双联抗血小板治疗后抗血小板反应性的相关性。方法 连续募集2020年10月至2022年3月于解放军总医院心血管内科住院并接受阿司匹林联合P2Y12受体拮抗剂治疗的ACS患者169例。所有患者在经双联抗血小板药物稳定剂量治疗后,行血栓弹力图(TEG)检测,采用二磷酸腺苷(ADP)诱导的血小板纤维蛋白凝块强度(MAADP)和ADP诱导的血小板抑制率(PIADP)反映抗血小板反应性。以PIADP 75%为界值,将患者分为低血小板反应性(LTPR)组106例(PIADP>75%)和高血小板反应性(HTPR)组63例(PIADP≤75%)。提取患者外周全血血小板RNA,通过荧光定量多重聚合酶链式反应(PCR)对血小板源性hsa_circ_0001535的相对表达水平进行检测。采用SPSS 27.0统计软件与R语言4.4.2软件进行数据分析。根据数据类型,组间比较分别采用t检验、Wilcoxon秩和检验或χ2检验。采用多因素logistic回归分析明确血小板源性hsa_circ_0001535相对表达水平与抗血小板反应性的相关性。结果 在169例患者中,血小板源性hsa_circ_0001535相对表达水平中位数为1.47(0.83,2.66),MAADP中位数为19.40(10.63,31.18),PIADP中位数为88.20%(55.04%,94.55%),均呈偏态分布。Spearmen相关性分析发现,血小板源性hsa_circ_0001535相对表达水平与PIADP呈负相关(r=-0.16,P=0.039)。HTPR组血小板源性hsa_circ_0001535的表达水平显著高于LTPR组[1.94(1.15,3.76)和1.28(0.59,2.14);P=0.0006]。多因素logistic回归分析发现,年龄(OR=1.07,95%CI 1.02~1.13;P=0.0071)、体质量指数(OR=0.82,95%CI 0.72~0.94;P=0.0030)、血小板源性hsa_circ_0001535相对表达水平(OR=1.22,95%CI 1.04~1.43;P=0.0160)、氯吡格雷(OR=2.45,95%CI 1.12~5.35;P=0.0242)及CYP2C19 LOF(OR=1.24,95%CI 1.01~1.51;P=0.0421)是ACS患者双联抗血小板治疗后抗血小板反应性的独立影响因素。结论 血小板源性hsa_circ_0001535的相对表达水平与ACS患者双联抗血小板治疗后抗血小板反应性呈独立相关性。

    Abstract:

    Objective To investigate the expression of platelet-derived circular RNA hsa_circ_0001535 and to analyze its correlation with antiplatelet reactivity in patients with acute coronary syndrome (ACS) after dual antiplatelet therapy. Methods A total of 169 consecutive ACS patients hospitalized in the Department of Cardiology of Chinese PLA General Hospital between October 2020 and March 2022 and treated with aspirin combined with a P2Y12 receptor antagonist were enrolled. All patients underwent thromboelasto-graphy (TEG) after receiving a single dose of dual antiplatelet therapy. Adenosine diphosphate (ADP)-induced platelet-fibrin clot strength (MAADP) of platelet-fibrin clot strength and ADP-induced platelet inhibition rate (PIADP) were used to reflect antiplatelet reactivity. With PIADP 75% as the cutoff value, patients were divided into a low on-treatment platelet reactivity group (LTPR group, n=106, PIADP > 75%) and a high on-treatment platelet reactivity group (HTPR group, n=63, PIADP≤ 75%). Platelet RNA was extracted from peripheral whole blood, and the relative expression level of hsa_circ_0001535 in platelets was detected by fluorescent quantitative multiplex polymerase chain reaction (PCR). Data analysis was performed using SPSS 27.0 and R language version 4.4.2. Based on data type, intergroup comparisons were conducted using the t-test, Wilcoxon rank-sum test, orχ2 test. Multivariate logistic regression analysis revealed that age (OR=1.07,95%CI 1.02-1.13; P=0.0071), body mass index (OR=0.82,95%CI 0.72-0.94; P=0.0030), platelet-derived hsa_circ_0001535 (OR=1.22,95%CI 1.04-1.43; P=0.0160) , clopidogrel (OR=2.45,95%CI 1.12-5.35; P=0.0242), and CYP2C19 loss-of-function (OR=1.24,95%CI 1.01-1.51; P=0.0421) were independent factors affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients. Results In the 169 patients, the median relative expression level of platelet-derived hsa_circ_0001535 was 1.47 (0.83,2.66), the median MA ADP was 19.40 (10.63,31.18), and the median PI ADP was 88.20% (55.04%, 94.55%), all showing a skewed distribution. Spearman correlation analysis found that the relative expression level of platelet-derived hsa_circ_0001535 was negatively correlated with PI ADP (r=-0.16, P=0.039). The expression level of platelet-derived hsa_circ_0001535 was significantly higher in the HTPR group than that in the LTPR group [1.94 (1.15,3.76) vs. 1.28 (0.59,2.14); P=0.0006)]. Multivariate logistic regression analysis revealed that platelet-derived hsa_circ_0001535 was an independent factor affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients (OR=1.22,95%CI 1.04-1.43; P=0.0160). Conclusion The relative expression level of platelet-derived hsa_circ_0001535 is independently correlated with antiplatelet reactivity in ACS patients after dual antiplatelet therapy.

    参考文献
    相似文献
    引证文献
引用本文

姚妍竹,王语嫣,毛帅,刘雨琪,赵芸漳,王一凡,吕超,尹彤.血小板源性hsa_circ_0001535与急性冠脉综合征患者双联抗血小板治疗后抗血小板反应性的相关性[J].中华老年多器官疾病杂志,2026,25(1):1-6
DOI:10.11915/j. issn.1671-5403.2026.01.001

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-07-08
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-01-20
  • 出版日期:
文章二维码